Target intelligence / Profile preview

Immunoglobulin heavy diversity 3-3 (IGHD3-3)

Target
IGHD3-3
Molecular classification
Other (Immunoglobulin gene segment—diversity region)
01

Overview

Immunoglobulin heavy diversity 3-3 (IGHD3-3) is one of approximately 25 functional diversity (D) gene segments within the immunoglobulin heavy chain (IGH) locus on chromosome 14[5][3]. During B cell development, a single D gene segment, such as IGHD3-3, recombines with specific variable (V) and joining (J) gene segments through the V(D)J recombination process. This generates the variable domain of immunoglobulin heavy chains essential for antigen specificity in antibodies[2]. The IGHD3-3 segment itself does not encode a full protein; rather, it contributes to the hypervariable region of the antibody, impacting antigen recognition and overall immune diversity[3][2]. IGHD3-3 is not considered a direct therapeutic target or receptor but is integral for immune repertoire diversity, and germline or somatic variation in this locus has been associated with differential immune responses in health and disease[4]. No drugs, drug mechanisms, or established biomarker roles are directly associated with IGHD3-3.

Other names
IGHD33DXP4
02

Biological functions

Immune responseAntigen recognitionGeneration of antibody (immunoglobulin) diversity
03

Disease associations

Other (Associated with general functioning of adaptive immunity; not a direct disease target, but variations may modulate immune responses[4][2])

Beyond the preview

Go deeper on Immunoglobulin heavy diversity 3-3 (IGHD3-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy diversity 3-3 (IGHD3-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call